2024-07-16 - CD Munich - Sanofi v. Amgen - UPC_CFI_1/2023

Aktenzeichen:
UPC_CFI_1/2023
Datum:
Spruchkörper:
Court of First Instance - Munich (DE) Central Division - Section
Art:
Proceeding Decision
Parteien:
Sanofi-Aventis Deutschland GmbH, Sanofi Winthrop Industrie S.A., Sanofi-Aventis Groupe v. Amgen, Inc.

Kernaussage: 1.

2024-07-16 - CD Munich - Sanofi v. Amgen - UPC_CFI_1/2023
Eine Entscheidung, mehrere Registereinträge

Das Gericht hat diese Verfahren zusammen entschieden und dasselbe Dokument in jedem davon eingestellt. Jeder Eintrag unten ist ein eigener vollwertiger Registereintrag.

  • UPC_CFI_1/2023 (Sie lesen diesen hier) Text zuerst hier gespeichert
  • UPC_CFI_1/2023
🏛️Court of First Instance - Munich (DE) Central Division - Section• Proceeding Decision
📅2024-07-16
🔢UPC_CFI_1/2023
Parteien & Vertreter
Kläger / Berufungsführer
Sanofi-Aventis Deutschland GmbH
Daniel WISE
Beklagter / Berufungsbeklagter
Amgen, Inc.
Koen BIJVANK
📋ORD_598362/2023
⚖️Revocation Action
🌐English

1. When interpreting a patent claim, the person skilled in the art does not apply a philological understanding, but determines the technical meaning of the terms used with the aid of the description and the drawings. From the function of the individual features in the context of the patent claim as a whole, it must be deduced which technical function these features actually have individually and as a whole. The patent description may represent a patent´s own lexicon. 2. A claimed invention is to be considered the “same invention” as meant in Article 87 EPC (priority right) if the skilled person can derive the subject-matter of the claim directly and unambiguously, using common general knowledge, from the previous application as a whole. 3. The assessment of inventive step starts from a realistic starting point in the prior art. There can be several realistic starting points. It is not necessary to identify the “most promising” starting point. 4. In general, a claimed solution is obvious if the skilled person would be motivated to consider the claimed solution and would implement it as a next step in developing the prior art. It may be relevant whether the skilled person would have expected any particular difficulties in taking any next step(s). The absence of a reasonable expectation of success (or more in general: non-obviousness) does not follow from the mere fact that other ways of solving the underlying problem are also suggested in the prior art and/or (would) have been pursued by others. The decisive question that has to be answered is whether the claimed solution is non-obvious. 5. For assessing inventive step it is not the question whether the skilled person would inevitably arrive at the same result (falling within the scope of the claim or not). Rather, it is sufficient (but also necessary) for denying inventive step that the skilled person would without inventive contribution arrive at a result which is covered by a claim. 6. A technical effect or advantage achieved by the claimed subject matter compared to the prior art may be an indication for inventive step. A feature that is selected in an arbitrary way out of several possibilities cannot generally contribute to inventive step.

Patent was entirely revoked
Stichwörter
Revocation, claim interpretation, priority, inventive step, starting point, obviousness, inventive contribution, arbitrary selection out of several possibilities

Nichtigkeitsgründe

Art. 138 EPC
5 Gründe
Novelty
Art. 54 EPC · Art. 138(1)(a) EPC
Patent survived (this ground)
“Novelty attack under Art. 54(3) EPC based on C1 and C2 fails because the Patent validly claims P3's priority [7.14].”
Inventive Step
Art. 56 EPC · Art. 138(1)(a) EPC
Patent invalid (this ground)
“Main Request and all 17 auxiliary requests held obvious over Lagace (C3); Lagace explicitly suggests antibody development blocking PCSK9/LDLR interaction; 'binds to catalytic domain' is an arbitrary selection [8.11-8.82, 9.7].”
Added Matter
Art. 123(2) EPC · Art. 138(1)(c) EPC
Not decided
“Added-matter objections raised but not decided on Main Request because revocation follows from lack of inventive step; auxiliary requests addressing added-matter fall with the MR [9.7, 9.8].”
Insufficiency of Disclosure
Art. 83 EPC · Art. 138(1)(b) EPC
Not decided
“Insufficiency attack raised but not decided — inventive step is decisive [9.8].”
Priority
Art. 87 EPC · derivative
Patent survived (this ground)
“Patent validly claims priority from P3 (9 January 2008) under the G-2/98 'same invention' standard; Figure 26 added in P4 is illustrative, not definitional [7.7-7.13].”
Feststellungen aus Sicht des Patentinhabers bezeichnet. Quelle: KI-Klassifikation (AI)

Entscheidung teilen

Weitere Navigation
Entscheidungen
Rechtstexte
Analysen

Zu Sammlung hinzufügen

0 Einträge hinzufügen zu:

Anmeldung

Registrieren